Skip to content
FINPEDMED
ENG
  • Stenbäckinkatu 11, FI-Helsinki
  • c4c.finpedmed@hus.fi
  • +358 50 514 2646

Informed Consent Form templates for paediatric clinical trials

The FINPEDMED Informed Consent Form (ICF) and Trial Information Sheet -template models are intended for the use of health care professionals and pharma industry conducting paediatric clinical trials in Finland.

In the current Finnish Medical Research Act, the term CONSENT is used in the context of minors’ (<15 yrs and 15-17 yrs) participation. This consent is required in written form. This term CONSENT is comparable to the term ASSENT (article 29(8) of the Clinical Trials Regulation, CTR, 16th April 2014). It gives no legal permission for minor´s (<15 yrs) participation and it is not valid alone, because it needs an additional consent of a guardian or other legal representative.

About the models:

  • The age grouping is according to the current law; children below 15-years old and 15-17 years old adolescents, based on the legal ability to give indpendent consent.
  • The ICF template for children under 15-years of age is INTEGRATED, i.e. it includes the main information and there is no need separate trial information sheet. However, it is preferred to provide some additional visual information for this age group, for example by using pictures, especially about the trial time schedule.
  • FINPEDMED Picture Cards or other equivalent material can be used to help understanding of the trial information. See: Picture cards.
  • Principally, the trial information given to children under 15 years of age is based on the guardian’s information sheet which is discussed thoroughly with both the guardian(s) of the child and the child, taking into account his/her level of understanding.
  • There should be a possibility for both parties to ask questions concerning the study and they should receive satisfactory answers to these questions from the person giving this information.
  • After this discussion, the child signs his/her own informed consent and upon signing, it is confirmed that the child has understood the information concerning him/her and that he/she is willing to participate in the trial.
  • After this procedure, the guardian(s) can sign the informed consent and thus give legal permission for their child’s participation.

The new templates for minors have been updated in 2021 according to the new EU General Data Protection Regulation (GDPR, EU 2016/679, implemented on 25th May 2018) together with the updated version of the ETHICAL CONSIDERATIONS FOR CLINICAL TRIALS ON MEDICINAL PRODUCTS CONDUCTED WITH THE PAEDIATRIC POPULATION (R1, 18th September 2017). New document have been created according to the GDPR for the 15-17 years old participants about the processing the personal data in clinical trials. All these document models have been designed together with the valuable comments provided by HUS Department of Children and Adolescents Resaerch Panel (Young Person´s Advisory Group). By this way, children and adolescents can be better involved to the decision makig processes related to their own interests and enhance the understanding of trial information during the informed consent process.

The new Informed Consent and Patient Information Sheet templates 2021:

Templates for paediatric clinical trials in Finnish and Swedish can be found here.

Maternal ICF for pregnant women for clinical drug trial or medical device trial can be found here.